The mood swings, the comments:Its, "Sad", "done nothing" but the reality is different of course. EXEL has done lots on its very typical biotech action. Initial over excitement on technology vs the reality of time and costs to prove up, apply anf hopefully then get approved. All the way high risks. Then when years go by the people who jumped in early, sell out often just before blast of, missing what they claimed they were waiting for. Go figure, when it ALWAYS takes years. Here that is true, but with opportunity to trade and do very well, as you wait with a core position. So its far from sad and has accomplished lots, giving it fantastic upside far more real than a decade ago. Reality check. That is the fact and situation.
I totally understand your sentiment....this has been a huge test of the will and endurance. Until we see objective data demonstrating efficacy, the stock will languish. Myself, I think we will eventually will see that demonstrated, and when we do, I will sell my shares, collect my millions, including your shares....so.....thanks!